Cost Expenditure Criteria for Research and Development Utilization Facilities

What it does

The U.S. Nuclear Regulatory Commission (NRC) is amending its regulations to address the financial criteria used to determine whether a utilization facility that is useful in the conduct of research and development activities is licensed as a commercial facility under section 103, "Commercial Licenses," of the Atomic Energy Act of 1954, as amended, or as a research and development facility under section 104, "Medical Therapy and Research and Development." This rulemaking revises the NRC's regulations to be consistent with the Nuclear Energy Innovation and Modernization Act, enacted on January 14, 2019, and the Accelerating Deployment of Versatile, Advanced Nuclear for Clean Energy Act of 2024, enacted on July 9, 2024.

The Nuclear Regulatory Commission's summary, as published in the Federal Register.

What changed in the regulation

1 part of Title 10 of the Code of Federal Regulations:

10 CFR 50

Wording on eCFR: the day before it took effect and from the day it took effect (first part listed).

Compared with

The Nuclear Regulatory Commission has published 34 final rules in 2026 so far, compared with 28 in all of 2025.

Counted by the Tribune from Federal Register records since Jan. 1, 2025.

Before this

No earlier Federal Register document under regulation identifier 3150-AL35 since Jan. 1, 2025.

What happens next and when

This final rule is effective on April 24, 2026.

The agency's dates, word for word.

Check it yourself

• The document in the Federal Register
• Docket NRC-2020-0071 on Regulations.gov
• Title 10 on eCFR

The record as published

Source: the Federal Register (public domain). The document in the Federal Register